Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIb study of MabThera (rituximab) maintenance therapy in follicular non-Hodgkin's lymphoma
2005-004977-12Phase 3Completed
- Sponsor
- Roche
- Start
- Jun 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of rituximab in follicular lymphoma (FL), sponsored by Roche. Primary endpoint: Safety (primary). Started Jun 2006; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on 2005-004977-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004977-12.